v3.25.2
SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS (Details) (Parenthetical) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Impairment charge         $ 1,271,306 [1]
Interest Expense, Operating and Nonoperating   $ 99,306 $ 346,402 $ 1,970,913 3,093,999 [2] 1,757,057
Accrued Salaries $ 310,000       310,000  
Prepaid expenses [2] (3,750) (19,117) (57,717) [2] (81,317)
Revenue   (122,006) (28,645) (29,109) (197,459) [3] (619,538)
Other liabilities 207,938 [3] 207,938 205,749 127,784 207,938 [3]
Revision of Prior Period, Adjustment [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Impairment charge [1]         1,271,306  
Interest Expense, Operating and Nonoperating 526,903       526,903 [2]  
Revenue   2,189 77,965 127,784 207,938 [3]  
Revision of Prior Period, Reclassification, Adjustment [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Prepaid expenses [2] 30,317       30,317  
Other liabilities $ 207,938 [3] $ 207,938 $ 205,749 $ 127,784 $ 207,938 [3]  
[1] Based on an annual review performed on December 31, 2023, the Company determined that its goodwill and intangible assets had been fully impaired and recorded an impairment charge amounting to $1,271,306.
[2] At year end December 31, 2023, the Company recorded the following charges and adjustments to the financial statement above. These entries only impacted the Company’s fourth quarter and had no impact on prior quarters: -$526,903 was recorded as default interest due to a notification by lender to the Company in Q4 of 2023 -$310,000 in accrued salary, board fees and accrued expenses which should have been recorded relating the Company’s Q4 activity, was not recorded
[3] Represents quarterly reduction of revenue which has been reclassified as an accrued liability due to the lack of documentation to support revenue recognition under the guidelines of ASC 606. The reduction in quarterly revenue amounted to $127,784 for the period ended March 31, 2023, $77,965 for the quarter ended June 30, 2023, and $2,189 for the quarter ended September 30, 2023. These adjustments amounted to $207,938. The quarterly restatement on the Company’s balance sheet and statements of operations of these revenue adjustments, which had no impact on cash flows, are reflected below.